Binding of some metastatic tumor cell lines to fibrous elastin and elastin peptides

1993 ◽  
Vol 53 (5) ◽  
pp. 824-828 ◽  
Author(s):  
Tatyana M. Svitkina ◽  
Donald F. Parsons
Biorheology ◽  
1995 ◽  
Vol 32 (2-3) ◽  
pp. 205-205
Author(s):  
D HAMMER ◽  
D GOETZ ◽  
B PAULI ◽  
B BRANDLEY

FEBS Letters ◽  
1997 ◽  
Vol 403 (2) ◽  
pp. 181-185 ◽  
Author(s):  
Martin A Cohn ◽  
Dmitri Kramerov ◽  
Egil F Hulgaard ◽  
Eugene M Lukanidin

1983 ◽  
Vol 50 (03) ◽  
pp. 726-730 ◽  
Author(s):  
Hamid Al-Mondhiry ◽  
Virginia McGarvey ◽  
Kim Leitzel

SummaryThis paper reports studies on the interaction between human platelets, the plasma coagulation system, and two human tumor cell lines grown in tissue culture: Melanoma and breast adenocarcinoma. The interaction was monitored through the use of 125I- labelled fibrinogen, which measures both thrombin activity generated by cell-plasma interaction and fibrin/fibrinogen binding to platelets and tumor cells. Each tumor cell line activates both the platelets and the coagulation system simultaneously resulting in the generation of thrombin or thrombin-like activity. The melanoma cells activate the coagulation system through “the extrinsic pathway” with a tissue factor-like effect on factor VII, but the breast tumor seems to activate factor X directly. Both tumor cell lines activate platelets to “make available” a platelet- derived procoagulant material necessary for the conversion of prothrombin to thrombin. The tumor-derived procoagulant activity and the platelet aggregating potential of cells do not seem to be inter-related, and they are not specific to malignant cells.


1989 ◽  
Vol 1 (6) ◽  
pp. 359-365 ◽  
Author(s):  
Richard D. H. Whelan ◽  
Louise K. Hosking ◽  
Alan J. Townsend ◽  
Kenneth H. Cowan ◽  
Bridget T. Hill

2006 ◽  
Vol 11 (3) ◽  
pp. 177-183 ◽  
Author(s):  
Kil-Nam Kim ◽  
Ki-Wan Lee ◽  
Choon-Bok Song ◽  
Chang-Bum Ahn ◽  
You-Jin Jeon

Sign in / Sign up

Export Citation Format

Share Document